1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
SpectraScience, Inc.

SpectraScience, Inc.

SCIE
SpectraScience, Inc.US flagOther OTC
0.00
USD
- -
- -
4,924.00Market Cap
2004 Y
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-0.01
-0.02
-0.03
-0.1
-0.08
-0.1
-0.07
-0.04
-0.08
-0.02
-0.03
-0.02
-0.01
- -
Free Cash Flow per Basic Share
-0.01
-0.02
-0.02
-0.04
-0.06
-0.04
-0.03
-0.03
-0.02
-0.01
-0.01
-0.01
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
-0.02
-0.06
-0.14
-0.17
-0.26
-0.26
-0.26
-0.31
-0.25
-0.26
-0.21
-0.06
-0.01
Tangible Book Value per Share
0.04
0.02
0.01
0.17
0.05
0.07
0.04
- -
-0.03
-0.03
-0.03
-0.04
-0.02
-0.01
Basic Weighted Avg Shares
32
38
38
42
66
70
92
108
119
160
170
216
698
1,836
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
-8,704.31
-2,654.82
-18,848.74
-17,832.77
-936.66
-1,138.21
- -
-37,626.88
-47,459.92
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-1
-1
-3
-5
-4
-4
-5
-9
-3
-4
-4
-4
-5
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
-8,495.54
-2,652.05
-17,330.33
-17,812.27
-1,971.1
-1,145.69
- -
-55,073.76
-86,729.46
- -
Working Capital
1
1
- -
6
2
4
4
- -
-3
-4
-6
-8
-10
-12
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
Total Equity
2
1
1
10
7
8
7
3
-2
-3
-4
-7
-11
-13
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Mar'17
Jun'17
Sep'17
ST Debt
6
6
7
LT Borrowings
1
1
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,413
1,963
4,824
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Mar'17
Jun'17
Sep'17
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
11
12
13
Payables & Accruals
4
4
5
ST Debt
6
6
7
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
187.45%
16.24%
50.24%
Free Cash Flow
21.1%
-10.62%
-19.95%
Net Income, GAAP
28.3%
17.66%
22.88%
Sales/Revenue/Turnover
- -
- -
-21.97%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2015
- -
- -
- -
- -
- -
2016
- -
- -
- -
- -
- -
2017
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2015
-0.01
- -
- -
- -
-0.02
2016
- -
- -
- -
- -
-0.01
2017
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2015
- -
- -
- -
- -
- -
2016
- -
- -
- -
- -
- -
2017
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Lowell W. Giffhorn
Full Time Employees
5
Sector
Healthcare
Industry
Medical - Specialties
Address
11568 Sorrento Valley Road San Diego MN United States of America
IPO Date
Aug 25, 2004
CIK
0000727672
Website
spectrascience.com
Similar Companies
Aidite Qinhuangdao Technology Co Ltd (301580.SZ)
GKB Ophthalmics Limited (GKB.BO)
WON TECH Co.,Ltd. (336570.KQ)
QuidelOrtho Corporation (0A55.L)
Shanghai United Imaging Healthcare Co., Ltd. (688271.SS)
enVVeno Medical Corporation (NVNBW)
Business
SpectraScience Inc (SCIE) develops and markets non-invasive optical biopsy systems for real-time tissue analysis to detect normal, pre-cancerous or cancerous conditions during endoscopic procedures in the United States, Europe and internationally. The company offers the WavSTAT3 optical biopsy system for colon tissue diagnosis without physical biopsy removal; WavSTAT4 optical biopsy system, which uses UV laser light for instant colon cancer screening; mobile consoles; disposable forceps; and develops esophageal diagnosis applications for pre-cancerous and cancerous tissue detection across various body sites. Founded in 1983 and headquartered at 11568 Sorrento Valley Road, San Diego, California, the company, formerly GV Medical Inc until its name change in October 1992, operates in the medical devices segment of healthcare with approximately seven employees. No major recent partnerships, funding rounds, acquisitions, product launches or strategic shifts reported in the last one to two years; the firm remains delinquent in SEC periodic filings since at least June 2023.

Company News

APIChat

  • newsfilecorp.com

    SEC Suspends Trading in Inactive Issuer Touted on Social Media

  • pulse2.com

    SCIE Stock Price Spikes This Past Week: Why It Happened